Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats
Norsyifa Harun, Illa Syafiqah Johari, Sharif Mahsufi Mansor, et al.
Psychopharmacology (2019) Vol. 237, Iss. 3, pp. 855-867
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9
The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats
Takato Hiranita, Francisco León, Jasmine S. Felix, et al.
Psychopharmacology (2019) Vol. 236, Iss. 9, pp. 2725-2734
Open Access | Times Cited: 45
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products
Islamudin Ahmad, Wisnu Cahyo Prabowo, Muhammad Arifuddin, et al.
Life (2022) Vol. 12, Iss. 2, pp. 193-193
Open Access | Times Cited: 19
Discovery of rhynchophylline and mitraphylline in two Thai Mitragyna species and the investigation of their biological activity via opioid gene expression analysis
Runglawan Sudmoon, Tawatchai Tanee, Warin Wonok, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 2, pp. 223-228
Closed Access | Times Cited: 27
Evaluation of the rewarding effects of mitragynine and 7‐hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats
Azin Behnood‐Rod, Ranjithkumar Chellian, Ryann Wilson, et al.
Drug and Alcohol Dependence (2020) Vol. 215, pp. 108235-108235
Open Access | Times Cited: 27
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
Cornel N. Stanciu, Saeed Ahmed, Samantha A. Gnanasegaram, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 5, pp. 509-528
Closed Access | Times Cited: 14
Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy
Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian, et al.
Neuroscience Letters (2022) Vol. 773, pp. 136500-136500
Closed Access | Times Cited: 11
Cross-reinstatement of mitragynine and morphine place preference in rats
Rima Atria Japarin, Nurul H.M. Yusoff, Zurina Hassan, et al.
Behavioural Brain Research (2020) Vol. 399, pp. 113021-113021
Closed Access | Times Cited: 17
Kratom withdrawal: Discussions and conclusions of a scientific expert forum
Jack E. Henningfield, Marek C. Chawarski, Albert Garcia‐Romeu, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100142-100142
Open Access | Times Cited: 6
Receptor Selectivity and Therapeutic Potential of Kratom in Substance Use Disorders
Sushobhan Mukhopadhyay, Sampa Gupta, Jenny L. Wilkerson, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 304-316
Closed Access | Times Cited: 6
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Rahimah Hassan, Sreenivasan Sasidharan, Christian P. Müller, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12
Mitragynine improves cognitive performance in morphine-withdrawn rats
Chiek Yi You, Zurina Hassan, Christian P. Müller, et al.
Psychopharmacology (2021) Vol. 239, Iss. 1, pp. 313-325
Closed Access | Times Cited: 12
Kratom as a potential substance use disorder harm reduction agent
MeShell Green, Nina Vadiei, Charles A. Veltri, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Dynamic Topic Modeling of Kratom Use and Experiences: Insights on 13 years of Reddit Discussions
Seraphina Fong, Alessandro Carollo, Elisabeth Prevete, et al.
(2024)
Open Access | Times Cited: 1
Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats
Rahimah Hassan, Nurulhasanah Othman, Sharif Mahsufi Mansor, et al.
Brain Research Bulletin (2021) Vol. 172, pp. 139-150
Closed Access | Times Cited: 9
Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats
Illa Syafiqah Johari, Norsyifa Harun, Zarif Mohamed Sofian, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3183-3191
Closed Access | Times Cited: 9
Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice
Kai Yue, Jonathan L. Katz, Xiji Shu
Psychopharmacology (2022) Vol. 239, Iss. 3, pp. 897-908
Closed Access | Times Cited: 6
Kratom: Substance of Abuse or Therapeutic Plant?
David A. Gorelick
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 3, pp. 415-430
Closed Access | Times Cited: 6
Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review
Alexandra Arenson, Cynthia I. Campbell, Ilan Remler
Journal of Addictive Diseases (2023) Vol. 42, Iss. 3, pp. 253-263
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top